Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance.

Jousselin A, Kelley WL, Barras C, Lew DP, Renzoni A.

Antimicrob Agents Chemother. 2013 Jul;57(7):3283-92. doi: 10.1128/AAC.00220-13. Epub 2013 Apr 29.

2.

Antimicrobial peptide exposure and reduced susceptibility to daptomycin: insights into a complex genetic puzzle.

Kelley WL, Lew DP, Renzoni A.

J Infect Dis. 2012 Oct;206(8):1153-6. Epub 2012 Aug 16. No abstract available.

PMID:
22904340
3.

The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus.

Jousselin A, Renzoni A, Andrey DO, Monod A, Lew DP, Kelley WL.

Antimicrob Agents Chemother. 2012 Jul;56(7):3629-40. doi: 10.1128/AAC.06264-11. Epub 2012 Apr 23.

4.

High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.

Uçkay I, Bernard L, Buzzi M, Harbarth S, François P, Huggler E, Ferry T, Schrenzel J, Renzoni A, Vaudaux P, Lew DP.

Antimicrob Agents Chemother. 2012 Mar;56(3):1258-64. doi: 10.1128/AAC.05808-11. Epub 2011 Dec 12.

5.

Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.

Vaudaux P, Huggler E, Rhys-Williams W, Love WG, Lew DP.

Int J Antimicrob Agents. 2011 Jun;37(6):576-9. doi: 10.1016/j.ijantimicag.2011.01.015. Epub 2011 Mar 16.

PMID:
21414759
6.

Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.

Didier JP, Villet R, Huggler E, Lew DP, Hooper DC, Kelley WL, Vaudaux P.

Antimicrob Agents Chemother. 2011 May;55(5):1946-52. doi: 10.1128/AAC.01407-10. Epub 2011 Feb 28.

7.

Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA.

Andrey DO, Renzoni A, Monod A, Lew DP, Cheung AL, Kelley WL.

J Bacteriol. 2010 Nov;192(22):6077-85. doi: 10.1128/JB.00146-10. Epub 2010 Sep 24.

8.

Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.

Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP.

Antimicrob Agents Chemother. 2010 Sep;54(9):3861-70. doi: 10.1128/AAC.00269-10. Epub 2010 Jun 14.

9.

[Holy virus!].

Calandra T, Lew DP.

Rev Med Suisse. 2010 Apr 7;6(243):699-700. French. No abstract available.

PMID:
20432989
10.

Exploring innate glycopeptide resistance mechanisms in Staphylococcus aureus.

Renzoni A, Kelley WL, Vaudaux P, Cheung AL, Lew DP.

Trends Microbiol. 2010 Feb;18(2):55-6. doi: 10.1016/j.tim.2009.11.005. Epub 2009 Dec 11. Review. No abstract available.

11.

Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.

Vaudaux P, Huggler E, Arhin FF, Moeck G, Renzoni A, Lew DP.

Int J Antimicrob Agents. 2009 Dec;34(6):540-3. doi: 10.1016/j.ijantimicag.2009.07.016. Epub 2009 Sep 9.

PMID:
19744838
12.

[Outpatient antibiotic use in urgent care - a controversy].

Lew DP, Calandra T.

Rev Med Suisse. 2009 Apr 1;5(197):707-8. French. No abstract available.

PMID:
19492512
13.

Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.

Vaudaux P, Fleury B, Gjinovci A, Huggler E, Tangomo-Bento M, Lew DP.

Antimicrob Agents Chemother. 2009 Jul;53(7):3150-2. doi: 10.1128/AAC.01612-08. Epub 2009 Apr 13.

14.

Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.

Renzoni A, Kelley WL, Barras C, Monod A, Huggler E, François P, Schrenzel J, Studer R, Vaudaux P, Lew DP.

Antimicrob Agents Chemother. 2009 Mar;53(3):903-11. doi: 10.1128/AAC.01287-08. Epub 2008 Dec 22.

15.

A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells.

Garzoni C, Francois P, Huyghe A, Couzinet S, Tapparel C, Charbonnier Y, Renzoni A, Lucchini S, Lew DP, Vaudaux P, Kelley WL, Schrenzel J.

BMC Genomics. 2007 Jun 14;8:171.

16.

Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat.

Vaudaux P, Kelley WL, Lew DP.

Clin Infect Dis. 2006 Oct 15;43(8):968-70. Epub 2006 Sep 8. No abstract available.

PMID:
16983606
17.

Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Renzoni A, Barras C, François P, Charbonnier Y, Huggler E, Garzoni C, Kelley WL, Majcherczyk P, Schrenzel J, Lew DP, Vaudaux P.

Antimicrob Agents Chemother. 2006 Sep;50(9):3048-61.

18.

Diagnosis and treatment of diabetic foot infections.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS; Infectious Diseases Society of America.

Plast Reconstr Surg. 2006 Jun;117(7 Suppl):212S-238S.

PMID:
16799390
19.

Tolerance of staphylococci to bactericidal antibiotics.

Vaudaux P, Lew DP.

Injury. 2006 May;37 Suppl 2:S15-9.

PMID:
16651066
20.
21.

Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.

Vaudaux P, Gjinovci A, Bento M, Li D, Schrenzel J, Lew DP.

Antimicrob Agents Chemother. 2005 Sep;49(9):3789-93.

22.

Induction of fibronectin adhesins in quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin or by sigma B transcription factor activity is mediated by two separate pathways.

Li D, Renzoni A, Estoppey T, Bisognano C, Francois P, Kelley WL, Lew DP, Schrenzel J, Vaudaux P.

Antimicrob Agents Chemother. 2005 Mar;49(3):916-24.

23.

Gelsolin mediates calcium-dependent disassembly of Listeria actin tails.

Larson L, Arnaudeau S, Gibson B, Li W, Krause R, Hao B, Bamburg JR, Lew DP, Demaurex N, Southwick F.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1921-6. Epub 2005 Jan 25.

24.

A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.

Schrenzel J, Harbarth S, Schockmel G, Genné D, Bregenzer T, Flueckiger U, Petignat C, Jacobs F, Francioli P, Zimmerli W, Lew DP; Swiss Staphylococcal Study Group.

Clin Infect Dis. 2004 Nov 1;39(9):1285-92. Epub 2004 Oct 11.

PMID:
15494904
25.

Diagnosis and treatment of diabetic foot infections.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS; Infectious Diseases Society of America.

Clin Infect Dis. 2004 Oct 1;39(7):885-910. Epub 2004 Sep 10. No abstract available.

PMID:
15472838
26.

Osteomyelitis.

Lew DP, Waldvogel FA.

Lancet. 2004 Jul 24-30;364(9431):369-79. Review.

PMID:
15276398
27.

Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Renzoni A, Francois P, Li D, Kelley WL, Lew DP, Vaudaux P, Schrenzel J.

Antimicrob Agents Chemother. 2004 Aug;48(8):2958-65.

28.

Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.

Bernard L, Vaudaux P, Rohner P, Huggler E, Armanet M, Pittet D, Lew DP, Schrenzel J.

J Microbiol Methods. 2004 May;57(2):231-9.

PMID:
15063063
29.

A recA-LexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus.

Bisognano C, Kelley WL, Estoppey T, Francois P, Schrenzel J, Li D, Lew DP, Hooper DC, Cheung AL, Vaudaux P.

J Biol Chem. 2004 Mar 5;279(10):9064-71. Epub 2003 Dec 29.

30.

Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.

Vaudaux P, Francois P, Bisognano C, Li D, Lew DP, Schrenzel J.

J Antimicrob Chemother. 2003 Jul;52(1):89-95. Epub 2003 May 29.

PMID:
12775678
31.

Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis.

Francois P, Tu Quoc PH, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Cramton SE, Götz F, Vaudaux P.

FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):135-40.

32.

Health state preference assessment in diabetic peripheral neuropathy.

Sullivan SD, Lew DP, Devine EB, Hakim Z, Reiber GE, Veenstra DL.

Pharmacoeconomics. 2002;20(15):1079-89.

PMID:
12456202
33.
34.

Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes.

Vaudaux P, Francois P, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Proctor RA, McNamara PJ, Peters G, Von Eiff C.

Infect Immun. 2002 Oct;70(10):5428-37.

35.
36.
37.

Functional specialization of calreticulin domains.

Nakamura K, Zuppini A, Arnaudeau S, Lynch J, Ahsan I, Krause R, Papp S, De Smedt H, Parys JB, Muller-Esterl W, Lew DP, Krause KH, Demaurex N, Opas M, Michalak M.

J Cell Biol. 2001 Sep 3;154(5):961-72. Epub 2001 Aug 27. Erratum in: J Cell Biol 2001 Dec 10;155(6):1083.

38.

Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1.

Sinha B, François PP, Nüsse O, Foti M, Hartford OM, Vaudaux P, Foster TJ, Lew DP, Herrmann M, Krause KH.

Cell Microbiol. 1999 Sep;1(2):101-17.

PMID:
11207545
39.
40.

Selective inhibition of IgG-mediated phagocytosis in gelsolin-deficient murine neutrophils.

Serrander L, Skarman P, Rasmussen B, Witke W, Lew DP, Krause KH, Stendahl O, Nüsse O.

J Immunol. 2000 Sep 1;165(5):2451-7.

41.

Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum.

Foyouzi-Youssefi R, Arnaudeau S, Borner C, Kelley WL, Tschopp J, Lew DP, Demaurex N, Krause KH.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):5723-8.

42.
43.

Inhibition by heparin and derivatized dextrans of Staphylococcus epidermidis adhesion to in vitro fibronectin-coated or explanted polymer surfaces.

Francois P, Letourneur D, Lew DP, Jozefonwicz J, Vaudaux P.

J Biomater Sci Polym Ed. 1999;10(12):1207-21.

PMID:
10673017
44.

Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion.

Francois P, Schrenzel J, Stoerman-Chopard C, Favre H, Herrmann M, Foster TJ, Lew DP, Vaudaux P.

J Lab Clin Med. 2000 Jan;135(1):32-42.

PMID:
10638692
45.

Vitronectin interaction with glycosaminoglycans. Kinetics, structural determinants, and role in binding to endothelial cells.

François PP, Preissner KT, Herrmann M, Haugland RP, Vaudaux P, Lew DP, Krause KH.

J Biol Chem. 1999 Dec 31;274(53):37611-9.

46.

Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.

Lew DP, Waldvogel FA.

Drugs. 1999;58 Suppl 2:85-91. Review.

PMID:
10553713
47.

The HIV Nef protein alters Ca(2+) signaling in myelomonocytic cells through SH3-mediated protein-protein interactions.

Foti M, Cartier L, Piguet V, Lew DP, Carpentier JL, Trono D, Krause KH.

J Biol Chem. 1999 Dec 3;274(49):34765-72.

48.

A novel H(+) conductance in eosinophils: unique characteristics and absence in chronic granulomatous disease.

Bánfi B, Schrenzel J, Nüsse O, Lew DP, Ligeti E, Krause KH, Demaurex N.

J Exp Med. 1999 Jul 19;190(2):183-94.

49.

Staphylococcal small colony variants have novel mechanisms for antibiotic resistance.

Proctor RA, Kahl B, von Eiff C, Vaudaux PE, Lew DP, Peters G.

Clin Infect Dis. 1998 Aug;27 Suppl 1:S68-74. Review.

PMID:
9710673
50.

Electron currents generated by the human phagocyte NADPH oxidase.

Schrenzel J, Serrander L, Bánfi B, Nüsse O, Fouyouzi R, Lew DP, Demaurex N, Krause KH.

Nature. 1998 Apr 16;392(6677):734-7.

PMID:
9565037

Supplemental Content

Support Center